INVESTMENT IN EQUITY INSTRUMENTS (Details Narrative) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Qualitative and Quantitative Information, Transferor's Continuing Involvement [Line Items] | ||
| Investments | $ 10,460,540 | $ 0 |
| Investment income | 65,540 | |
| Licensing And Development Arrangements [Member] | ||
| Qualitative and Quantitative Information, Transferor's Continuing Involvement [Line Items] | ||
| Investments | $ 10,460,540 |
| X | ||||||||||
- Definition Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|